Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

January 01, 1999; Volume 288,Issue 1

Articles

  • You have access
    Dithiocarbamate Pesticides Affect Glutamate Transport in Brain Synaptic Vesicles
    Andrea Vaccari, Pierluigi Saba, Ignazia Mocci and Stefania Ruiu
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 1-5;
  • You have access
    ONO-1603, a Potential Antidementia Drug, Delays Age-Induced Apoptosis and Suppresses Overexpression of Glyceraldehyde-3-Phosphate Dehydrogenase in Cultured Central Nervous System Neurons
    Nobuo Katsube, Katsuyoshi Sunaga, Hideki Aishita, De-Maw Chuang and Ryoichi Ishitani
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 6-13;
  • You have access
    Blockade of Striatal Dopamine Transporters by Intravenous Methylphenidate Is Not Sufficient to Induce Self-Reports of “High”
    Nora D. Volkow, Gene-Jack Wang, Joanna S. Fowler, S. John Gatley, Jean Logan, Yu-Shin Ding, Stephen L. Dewey, Robert Hitzemann, Andrew N. Gifford and Naomi R. Pappas
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 14-20;
  • You have access
    Three-Dimensional Quantitative Structure Activity Relationship Analyses of Substrates for CYP2B6
    Sean Ekins, Gianpaolo Bravi, Barbara J. Ring, Todd A. Gillespie, Jennifer S. Gillespie, Mark Vandenbranden, Steven A. Wrighton and James H. Wikel
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 21-29;
  • You have access
    Chronic Morphine Treatment Selectively Augments Metabotropic Glutamate Receptor-Induced Inhibition of N-Methyl-d-Aspartate Receptor-Mediated Neurotransmission in Nucleus Accumbens
    Gilles Martin, Riszard Przewlocki and George R. Siggins
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 30-35;
  • You have access
    RhoA-Sensitive Trafficking of Muscarinic Acetylcholine Receptors
    Oliver Vögler, Patrick Krummenerl, Martina Schmidt, Karl H. Jakobs and Chris J. Van Koppen
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 36-42;
  • You have access
    Effect of Overproduction of Interleukin 5 on Dinitrofluorobenzene-Induced Allergic Cutaneous Response in Mice
    Hiroichi Nagai, Yoshifumi Ueda, Hiroyuki Tanaka, Yousuke Hirano, Nobuaki Nakamura, Naoki Inagaki, Kiyoshi Takatsu and Kenji Kawada
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 43-50;
  • You have access
    Detection of 2-Hydroxyiminostilbene in the Urine of Patients Taking Carbamazepine and Its Oxidation to a Reactive Iminoquinone Intermediate
    C. Ju and J. P. Uetrecht
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 51-56;
  • You have access
    Renal Drug Targeting Using a Vector “Alkylglycoside”
    Kokichi Suzuki, Hiroshi Susaki, Satoshi Okuno and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 57-64;
  • You have access
    Diclofenac Toxicity to Hepatocytes: A Role for Drug Metabolism in Cell Toxicity
    Roque Bort, Xavier Ponsoda, Ramiro Jover, M. José Gómez-Lechón and José V. Castell
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 65-72;
  • You have access
    Neomycin Inhibits Catecholamine Secretion by Blocking Nicotinic Acetylcholine Receptors in Bovine Adrenal Chromaffin Cells
    Kyong-Tai Kim, Se-Young Choi and Tae-Ju Park
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 73-80;
  • You have access
    Chronic Clomipramine and Triiodothyronine Increase Serotonin Levels in Rat Frontal Cortex In Vivo: Relationship to Serotonin Autoreceptor Activity
    Eitan Gur, Bernard Lerer and Michael E. Newman
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 81-87;
  • You have access
    Noncompetitive Functional Inhibition at Diverse, Human Nicotinic Acetylcholine Receptor Subtypes by Bupropion, Phencyclidine, and Ibogaine
    John D. Fryer and Ronald J. Lukas
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 88-92;
  • You have access
    Propulsion in Guinea Pig Colon Induced by 5-Hydroxytryptamine (HT) via 5-HT4 and 5-HT3 Receptors
    J.-G. Jin, A. E. Foxx-Orenstein and J. R. Grider
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 93-97;
  • You have access
    Daily Injections of Fluoxetine Induce Dose-Dependent Desensitization of Hypothalamic 5-HT1A Receptors: Reductions in Neuroendocrine Responses to 8-OH-DPAT and in Levels of Gz and Gi Proteins
    D. K. Raap, S. Evans, F. Garcia, Q. Li, N. A. Muma, W. A. Wolf, G. Battaglia and L. D. Van De Kar
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 98-106;
  • You have access
    Increasing Doses of Pentoxifylline as a Continuous Infusion in Canine Septic Shock
    Zenaide M. N. Quezado, William D. Hoffman, Steven M. Banks, Robert L. Danner, Peter Q. Eichacker, Gregory M. Susla and Charles Natanson
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 107-113;
  • You have access
    Treatment with Liposome-Bound Recombinant Human Tumor Necrosis Factor-α Suppresses Parasitemia and Protects againstPlasmodium berghei k173-Induced Experimental Cerebral Malaria in Mice
    N. S. Postma, D. J. A. Crommelin, W. M. C. Eling and J. Zuidema
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 114-120;
  • You have access
    [S]-AR-R 15896AR—A Novel Anticonvulsant: Acute Safety, Pharmacokinetic and Pharmacodynamic Properties
    Gene C. Palmer, Robert J. Murray, Carrie L. Cramer, Mary L. Stagnitto, Marilyn K. Knowles, Lou R. Freedman, Mark S. Eismann, Nik Mahmood, Mike Balestra, Alfonso R. Borrelli, Thomas J. Hudzik and Dennis J. McCarthy
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 121-132;
  • You have access
    Inhibitory Effect of Rebamipide on the Neutrophil Adherence Stimulated by Conditioned Media from Helicobacter pylori-Infected Gastric Epithelial Cells
    Chi Dae Kim, Hyun Hee Kim and Ki Whan Hong
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 133-138;
  • You have access
    Mechanisms of Antihyperglycemic Effects of Moxonidine in the Obese Spontaneously Hypertensive Koletsky Rat (SHROB)
    Paul Ernsberger, Tatsuya Ishizuka, Sha Liu, Craig J. Farrell, David Bedol, Richard J. Koletsky and Jacob E. Friedman
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 139-147;
  • You have access
    Insights Into the Unusual Alpha Adrenoceptor Subtype in Dog Saphenous Vein Using Phenoxybenzamine
    A. M. Low, H. Lu-Chao, J. C. P. Loke, C. Y. Kwan and E. E. Daniel
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 148-156;
  • You have access
    Uptake of Fentanyl in Pulmonary Endothelium
    Christopher M. Waters, Michael J. Avram, Tom C. Krejcie and Thomas K. Henthorn
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 157-163;
  • You have access
    Selectivity Profile of Muscarinic Toxin 3 in Functional Assays of Cloned and Native Receptors
    Maria C. Olianas, Angela Ingianni, Carlo Maullu, Abdu Adem, Evert Karlsson and Pierluigi Onali
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 164-170;
  • You have access
    Modulation of the Permeability of H2 Receptor Antagonists Cimetidine and Ranitidine by P-Glycoprotein in Rat Intestine and the Human Colonic Cell Line Caco-2
    A. Collett, N. B. Higgs, E. Sims, M. Rowland and G. Warhurst
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 171-178;
  • You have access
    Altered Plasma and Brain Disposition and Pharmacodynamics of Methadone in Abstinent Rats
    María J. Garrido, Marta Valle, Rosario Calvo and Iñaki F. Trocóniz
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 179-187;
  • You have access
    Subjective and Physiological Effects of Intravenous Nicotine and Cocaine in Cigarette Smoking Cocaine Abusers
    Hendrée E. Jones, Bridgette E. Garrett and Roland R. Griffiths
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 188-197;
  • You have access
    High-Affinity Efflux Transport System for Glutathione Conjugates on the Luminal Membrane of a Mouse Brain Capillary Endothelial Cell Line (MBEC4)
    Masashi Homma, Hiroshi Suzuki, Hiroyuki Kusuhara, Mikihiko Naito, Takashi Tsuruo and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 198-203;
  • You have access
    Differences in Degree of Trapping of Low-Affinity UncompetitiveN-Methyl-d-aspartic Acid Receptor Antagonists with Similar Kinetics of Block
    G. A. R. Mealing, T. H. Lanthorn, C. L. Murray, D. L. Small and P. Morley
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 204-210;
  • You have access
    Potentiation of Ethanol Effects in Cerebellum by Activation of Endogenous Noradrenergic Inputs
    Yun Wang, Ronald K. Freund and Michael R. Palmer
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 211-220;
  • You have access
    Characterization of (S)-Des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a Selective High-Affinity Radioligand for 5-Hydroxytryptamine3 Receptors
    William A. Hewlett, Bakula L. Trivedi, Zhang-Jin Zhang, Tomas de Paulis, Dennis E. Schmidt, David M. Lovinger, M. Sib Ansari and Michael H. Ebert
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 221-231;
  • You have access
    GαL1 (Gα14) Couples the Opioid Receptor-Like1 Receptor to Stimulation of Phospholipase C
    Lisa Y. Yung, Sushma A. Joshi, Robbie Y.K. Chan, Joy S.C. Chan, Gang Pei and Yung H. Wong
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 232-238;
  • You have access
    Mechanisms and Sites of Action of Endothelins 1 and 2 on the Opossum Internal Anal Sphincter Smooth Muscle Tone In Vitro
    Sushanta Chakder and Satish Rattan
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 239-246;
  • You have access
    Long-Term Sequential Determination of Behavioral Ontogeny of 5-HT1A and 5-HT2 Receptor Functions in the Rat
    Nissar A. Darmani and Bashir Ahmad
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 247-253;
  • You have access
    Peroxisomes Are Involved in the Swift Increase in Alcohol Metabolism
    Blair U. Bradford, Nobuyuki Enomoto, Kenichi Ikejima, Michelle L. Rose, Heidi K. Bojes, Donald T. Forman and Ronald G. Thurman
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 254-259;
  • You have access
    Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions
    M. J. Kreek, J. Schluger, L. Borg, M. Gunduz and A. Ho
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 260-269;
  • You have access
    The In Vivo Unidirectional Conversion of Nitro-d-arginine to Nitro-l-arginine
    Qiong Wang, Michael Cwik, Catherine J. Wright, Francesca Cunningham and Dale A. Pelligrino
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 270-273;
  • You have access
    Synergistic Elevations in Nucleus Accumbens Extracellular Dopamine Concentrations during Self-Administration of Cocaine/Heroin Combinations (Speedball) in Rats
    Scott E. Hemby, Conchita Co, Steven I. Dworkin and James E. Smith
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 274-280;
  • You have access
    Specific Delivery of Captopril to the Kidney with the Prodrug Captopril-Lysozyme
    R. J. Kok, F. Grijpstra, R. B. Walthuis, F. Moolenaar, D. de Zeeuw and D. K. F. Meijer
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 281-285;
  • You have access
    Pharmacologic Actions of the Second-Generation Leukotriene B4 Receptor Antagonist LY293111: In Vitro Studies
    William T. Jackson, Larry L. Froelich, Robert J. Boyd, James P. Schrementi, David L. Saussy, Richard M. Schultz, J. Scott Sawyer, Michael J. Sofia, David K. Herron, Theodore Goodson, David W. Snyder, Penni A. Pechous, Stephen M. Spaethe, Carlos R. Roman and Jerome H. Fleisch
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 286-294;
  • You have access
    Effects of α- and β-Adrenoceptor Blockade on Purine Secretion Induced by Sympathetic Nerve Stimulation in the Rat Kidney
    Zaichuan Mi and Edwin K. Jackson
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 295-301;
  • You have access
    Novel 3α-Diphenylmethoxytropane Analogs: Selective Dopamine Uptake Inhibitors with Behavioral Effects Distinct from Those of Cocaine
    Jonathan L. Katz, Sari Izenwasser, Richard H. Kline, Andrew C. Allen and Amy Hauck Newman
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 302-315;
  • You have access
    Levosimendan, a Calcium Sensitizer in Cardiac Muscle, Induces Relaxation in Coronary Smooth Muscle Through Calcium Desensitization
    Peggy Bowman, Heimo Haikala and Richard J. Paul
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 316-325;
  • You have access
    Metabolic Transformations of Leukotriene B4 in Primary Cultures of Human Hepatocytes
    Pat Wheelan, Joseph A. Hankin, Bahri Bilir, Denis Guenette and Robert C. Murphy
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 326-334;
  • You have access
    Full and Partial 5-HT1A Receptor Agonists Disrupt Learning and Performance in Rats
    P. J. Winsauer, F. H. Rodriguez, A. E. Cha and J. M. Moerschbaecher
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 335-347;
  • You have access
    Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay
    Stephan Döppenschmitt, Peter Langguth, Carl Gunnar Regårdh, Tommy B. Andersson, Constanze Hilgendorf and Hildegard Spahn-Langguth
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 348-357;
  • You have access
    Evaluation of Proteinase-Activated Receptor-1 (PAR1) Agonists and Antagonists Using a Cultured Cell Receptor Desensitization Assay: Activation of PAR2 by PAR1-Targeted Ligands
    Atsufumi Kawabata, Mahmoud Saifeddine, Bahjat Al-Ani, Lorraine Leblond and Morley D. Hollenberg
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 358-370;
  • You have access
    Preclinical Pharmacokinetics, Interspecies Scaling, and Tissue Distribution of a Humanized Monoclonal Antibody against Vascular Endothelial Growth Factor
    Yvonne S. Lin, Cindy Nguyen, Jose-Luis Mendoza, Enrique Escandon, David Fei, Y. Gloria Meng and Nishit B. Modi
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 371-378;
  • You have access
    Differential Actions of Pacific Ciguatoxin-1 on Sodium Channel Subtypes in Mammalian Sensory Neurons
    Liesl C. Strachan, Richard J. Lewis and Graham M. Nicholson
    Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 379-388;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 288 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 288, Issue 1
1 Jan 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics